Non‐surgical treatment of peri‐implant mucositis and peri‐implantitis at zirconia implants: a prospective case series. (26th August 2015)

• Record Type: Journal Article
• Authors: Schwarz, Frank; John, Gordon; Hegewald, Andrea; Becker, Jürgen
• Is Part Of: Journal of clinical periodontology. Volume 42:Number 8(2015:Aug.)
• Page Start: 783
• Page End: 788
• Publication Date: 2015-08-26
• Subjects: Periodontics -- Periodicals; 617.6
• DOI: 10.1111/jcpe.12439
• Languages: English
• ISSNs: 0303-6979

Abstract

<abstract abstract-type="main" id="jcpe12439-abs-0001"> <title>Abstract</title> <sec id="jcpe12439-sec-0001" sec-type="section"> <title>Objectives</title> <p>To assess the efficacy of non‐surgical therapy for the management of peri‐implant diseases at a two‐piece zirconium implant system.</p> </sec> <sec id="jcpe12439-sec-0002" sec-type="section"> <title>Material & Methods</title> <p>Thirty‐four patients with 45 implants participated in this study. Seventeen patients (24 implants) were diagnosed with peri‐implant mucositis and received mechanical debridement + local antiseptic therapy using chlorhexidine digluconate (MD + CXH), while 17 patients (21 implants) diagnosed with peri‐implantitis were assigned to Er:YAG laser therapy. In both groups, post‐operative maintenance care included supramucosal plaque removal and local pocket irrigation using CHX. The primary endpoint was defined as disease resolution at 6 months (i.e. absence of bleeding upon probing (BOP) at mucositis sites/absence of BOP and probing pocket depths (PD) ≥6 mm at peri‐implantitis sites).</p> </sec> <sec id="jcpe12439-sec-0003" sec-type="section"> <title>Results</title> <p>Resolution of peri‐implant mucositis and peri‐implantitis was obtained in 9/17 (52.9%) (<italic>p </italic>=<italic> </italic>0.001) and 5/17 (29.4%) (<italic>p </italic>=<italic> </italic>0.02) of the patients respectively.</p> </sec> <sec id="jcpe12439-sec-0004" sec-type="section"> <title>Conclusion</title> <p>Non‐surgical treatment of either peri‐implant mucositis using MD + CHX or peri‐implantitis using ERL at zirconia implants was associated with significant short‐term clinical improvements. A complete disease resolution, however, was not achieved in the majority of the patients.</p> </sec> </abstract>